CBD in oral use, what changes?

The Italian regulatory landscape has undergone significant changes related to CBD for oral use in the past two months. Initially, the Speranza Decree of 2020 classified CBD for oral use as a narcotic, requiring it to be available for purchase in pharmacies by prescription only. However, this decision was later suspended by the Lazio Regional Administrative Court, leading to a number of impacts. As of September 20, 2023, cannabis light stores, both online and physical, could no longer freely sell CBD oil for oral use. This has sparked debate and concern, as the decree appears to have disregarded international recommendations, including that of the World Health Organization, which considers CBD for safe oral use and not a drug. The suspension of the decree was welcomed by CBD advocates, but the Light Cannabis sector in Italy continues to face economic and social challenges.CBD regulation remains an evolving topic.

In the past two months, the Italian regulatory landscape has been profoundly
shaped by the officialization of the 2020 Hope Decree by thes

Minister of Health, Orazio Schillaci, who included CBD for oral use  in the list of narcotic substances, making it mandatory to be purchased in pharmacies only by prescription and from the
subsequent suspension of the same by the Lazio Regional Administrative Court.

This decree, which went into effect on September 20, 2023, had had a significant impact on the economy of the Hemp sector in Italy, as from that date on, cannabis light stores, both online and physical, could no longer freely sell CBD oil for oral use.

The government’s decision has thus triggered a number of significant changes in our country, raising debates and concerns.
In this article, we will explore the implications of the decree and the latest updates about it, analyzing how they affect the way we live and interact  with  nonpsychotropic cannabinoids and how CBD for oral use has long since entered our homes.

In recent years, interest in Cannabidiol, better known as CBD, has grown exponentially. The subject of much scientific research, it has gained popularity for the potential
therapeutic
in a range of medical conditions such as chronic pain, anxiety, insomnia, and epilepsy.  It is precisely these points that have elicited considerableinterest among patients and consumers of CBD for oral use looking for alternatives to traditional drugs.

One point of concern is the fact that the new decree did not consider the opinion of the Superior Health Council, as required by current regulations. This raises questions about the motivation behind the decree and the possibility that there may be interests behind this decision that go beyond science and public health.

It is important to note that the World Health Organization, in December 2017, recommended internationally that Cannabidiol should not be considered a narcotic, as it is safe. This recommendation was later supported by the Court of Justice of the European Union in November 2020.

Marco Perduca said, “The decree does not take into account the recommendations of the World Health Organization nor the rulings of the European Court of Justice, which, on the one hand, recommend access to therapeutic Cannabidiol and, on the other hand, deem illegal the prohibition of products recognized as safe and effective in other EU member states.”

The Cannabis Light market in Italy generates about 150 million euros a year,
boffering employment to more than 10,000 people
. However, with the enactment of the
there would be not only economic but also social damage,
especially for small retailers such as herbalists and cannabis
light shops. Moreover, the impacts would also extend to online shops, which
would have to navigate the guidelines in order to minimise the impact. Overall,
all companies that have invested in the production, processing
and marketing of CBD would face the consequences of
this decree, bringing with it significant challenges for the sector and
employment in the country.

CBD for oral use: suspension of the decree

The  suspension of the decree had  an immediate impact on the situation of the

CBD products in Italy. Prior to the suspension, law enforcement agencies
had started to confiscate such products at points of sale, as their
detention had become illegal. The suspension now allows them to wait
the merit hearing set for Oct. 24, when the question will be discussed
in detail.

The ICI Association and other CBD supporters welcomed this suspension
as a major victory. They believe that the decree was
an ‘unscientific, illogical and harmful’ measure for the Italian hemp industry
and for citizens who had benefited from the use of CBD.

This episode highlights the importance of the judicial system
in ensuring compliance with laws and regulations. However, it also raises
questions about the government’s ability to draft adequate and well-considered laws,
especially when it comes to complex issues such as
of CBD.The regulation of CBD in Italy remains an evolving topic of
discussion, and the suspension of the decree represents a
significant development in this ongoing debate.

Try CBD oil  in our store, along with many  other products!

What are your thoughts    on this? Let us know in the comments what you think!

Leave a Reply

Your email address will not be published. Required fields are marked *

Open chat
Ciao,
vorrei informazioni sui vostri prodotti !